M. Rafiq

First name

M.

Last name

Rafiq

Rafiq, M., Abel, G., Renzi, C., & Lyratzopoulos, G. (2022). Steroid prescribing in primary care increases prior to Hodgkin lymphoma diagnosis: A UK nationwide case-control study. Cancer Epidemiol, 81, 102284. http://doi.org/10.1016/j.canep.2022.102284

View

Rafiq, M., Abel, G., Renzi, C., & Lyratzopoulos, G. (2022). Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years. Br J Gen Pract, 72, e546-e555. http://doi.org/10.3399/bjgp.2021.0617

View

Rafiq, M., Hayward, A., Warren-Gash, C., Denaxas, S., Gonzalez-Izquierdo, A., Lyratzopoulos, G., & Thomas, S. (2019). Socioeconomic deprivation and regional variation in Hodgkin\textquoterights lymphoma incidence in the UK: a population-based cohort study of 10 million individuals. BMJ Open. http://doi.org/10.1136/bmjopen-2019-029228

View

Rockenschaub, P., Jhass, A., Freemantle, N., Aryee, A., Rafiq, M., Hayward, A., & Shallcross, L. (2019). Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD). J Antimicrob Chemother. http://doi.org/10.1093/jac/dkz411

View

Rafiq, M., Hayward, A., Warren-Gash, C., Denaxas, S., Gonzalez-Izquierdo, A., Lyratzopoulos, G., & Thomas, S. (2019). Allergic disease, corticosteroid use and risk of Hodgkin\textquoterights lymphoma: A UK Nationwide case-control study. J Allergy Clin Immunol. http://doi.org/10.1016/j.jaci.2019.10.033

View